Max Mamonkin is currently an Associate Professor at Baylor College of Medicine, specializing in developing CAR-T for hematologic malignancies and alloimmunity. Prior to this role, Max held positions as an Assistant Professor, Instructor, Postdoctoral Associate, and PhD student, focusing on adoptive T cell therapies and CAR T cells. Max is also the Co-Founder and CSO of March Biosciences, with a PhD in Immunology from Baylor College of Medicine. They also hold a Specialist degree in Molecular Biology from Novosibirsk State University.
January, 2023 - present